Current evidence on the relationship between two polymorphisms in the NBS1 gene and breast cancer risk: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5375-5379

  Zhang, Zhi Hua ^a   Yang, Lin Sheng ^a   Huang, Fen ^a   Hao, Jia Hu ^a   Su, Pu Yu ^a   Sun, Ye Huan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

657del5 mutation; Analysis; Breast cancer; Cancer risk; I171V mutation; Meta; NBS1 gene; Polymorphism

Indexed keywords

EID: 84874083026     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5375     Document Type: Article

References (21)

1. Bogdanova N, Feshchenko S, Schurmann P, et al (2008a). Nijmegen Breakage Syndrome mutations and risk of breast cancer. Int J Cancer, 122, 802-6.
2. Bogdanova N, Schurmann P, Waltes R, et al (2008b). NBS1 variant I171V and breast cancer risk. Breast Cancer Res Treat, 112, 75-9.
3. Buslov KG, Iyevleva AG, Chekmariova EV, et al (2005). NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int J Cancer, 114, 585-9.
4. Carlomagno F, Chang-Claude J, Dunning AM, et al (1999). Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer. Genes Chromosomes Cancer, 25, 393-5.
5. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
6. Desjardins S, Beauparlant JC, Labrie Y, et al (2009). Variations in the NBN/NBS1 gene and the risk of breast cancer in non- BRCA1/2 French Canadian families with high risk of breast cancer. BMC Cancer, 9, 181.
7. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
8. Gorski B, Cybulski C, Huzarski T, et al (2005). Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat, 92, 19-24.
9. Gorski B, Debniak T, Masojc B, et al (2003). Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer, 106, 379-81.
10. Kanka C, Brozek I, Skalska B, et al (2007). Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland. Anticancer Res, 27, 3015-8.
11. Lau J, Ioannidis JP, and Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6.
12. Mantel N, and Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
13. Mosor M, Ziolkowska I, Pernak-Schwarz M, et al (2006). Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia, 20, 1454-6.
14. Nowak J, Mosor M, Ziolkowska I, et al (2008). Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours. Eur J Cancer, 44, 627-30.
15. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
16. Pharoah PD, Dunning AM, Ponder BA, et al (2004). Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer, 4, 850-60.
17. Roznowski K, Januszkiewicz-Lewandowska D, Mosor M, et al (2008). I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res Treat, 110, 343-8.
18. Steffen J, Nowakowska D, Niwinska A, et al (2006). Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int J Cancer, 119, 472-5.
19. Steffen J, Varon R, Mosor M, et al (2004). Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer, 111, 67-71.
20. Varon R, Seemanova E, Chrzanowska K, et al (2000). Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet, 8, 900-902.
21. Ziolkowska I, Mosor M, Wierzbicka M, et al (2007). Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci, 98, 1701-5.